TrialCancer immunology, immunotherapy : CII2021

Novel adjuvant dendritic cell therapy with transfection of heat-shock protein 70 messenger RNA for patients with hepatocellular carcinoma: a phase I/II prospective randomized controlled clinical trial.

Hiroto Matsui Matsui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.